Literature DB >> 29288735

Myelin changes at the early stage of 5XFAD mice.

Lihua Gu1, Di Wu1, Xiang Tang1, Xinyang Qi1, Xiaoli Li1, Feng Bai1, Xiaochun Chen2, Qingguo Ren3, Zhijun Zhang4.   

Abstract

Previous studies have demonstrated myelin deficits in Alzheimer's disease (AD). However, it is still unclear whether myelin deficits occur at early stage of AD. Our study aimed to investigate myelin deficits in 5XFAD mice dynamically in different cognition-associated brain regions at early stage of AD. Transmission electron microscopy (TEM) was applied to detect myelin changes in late-myelinating regions such as prelimbic area (PrL), retrosplenial granular cortex (Rsg), field CA1 of hippocampus (CA1) and entorhinal cortex (ERC) respectively at different stages (1, 2, 3 and 5 months of age) in 5XFAD mouse model. In addition, we assessed spatial learning and memory with Morris water maze (MWM) in 5XFAD mice. Myelin deficits in 5XFAD mice started from 1 month of age and this deterioration continued during ageing, whereas the same myelin abnormality could only be observed in 5-month-old wild-type mice. Additionally, the g-ratio (an index associated with myelin thickness) was increased in 1-month-old 5XFAD mice in the regions including PrL, CA1 and ERC, compared to wild-type mice. As animals aged, the increased g-ratio in 5XFAD appeared in more regions of the brain. Moreover, 5XFAD mice showed spatial memory deficits from 1 month of age and spatial learning deficits from 2 months of age. In conclusion, myelin deficits occurred at an early stage and progressed with ageing in 5XFAD mouse model. Notably, a sequential myelin change was detected in cognition-associated brain regions. Combined with cognitive examinations, this study suggests that myelin changes might contribute to cognitive dysfunction.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  5XFAD mice; Alzheimer’s disease; Cognition; Myelin

Mesh:

Substances:

Year:  2017        PMID: 29288735     DOI: 10.1016/j.brainresbull.2017.12.013

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  14 in total

1.  Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model.

Authors:  Robert J Andrew; Pierre De Rossi; Phuong Nguyen; Haley R Kowalski; Aleksandra J Recupero; Thomas Guerbette; Sofia V Krause; Richard C Rice; Lisa Laury-Kleintop; Steven L Wagner; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2019-01-28       Impact factor: 5.157

2.  Alterations in synaptic density and myelination in response to exposure to high-energy charged particles.

Authors:  Dara L Dickstein; Ronan Talty; Erin Bresnahan; Merina Varghese; Bayley Perry; William G M Janssen; Allison Sowa; Erich Giedzinski; Lauren Apodaca; Janet Baulch; Munjal Acharya; Vipan Parihar; Charles L Limoli
Journal:  J Comp Neurol       Date:  2018-11-08       Impact factor: 3.215

3.  Transcranial focused ultrasound, pulsed at 40 Hz, activates microglia acutely and reduces Aβ load chronically, as demonstrated in vivo.

Authors:  M S Bobola; L Chen; C K Ezeokeke; T A Olmstead; C Nguyen; A Sahota; R G Williams; P D Mourad
Journal:  Brain Stimul       Date:  2020-04-01       Impact factor: 8.955

Review 4.  Autophagy and apoptosis cascade: which is more prominent in neuronal death?

Authors:  Rohan Gupta; Rashmi K Ambasta
Journal:  Cell Mol Life Sci       Date:  2021-11-06       Impact factor: 9.261

5.  Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice.

Authors:  Donald G Matthews; Maya Caruso; Charles F Murchison; Jennifer Y Zhu; Kirsten M Wright; Christopher J Harris; Nora E Gray; Joseph F Quinn; Amala Soumyanath
Journal:  Antioxidants (Basel)       Date:  2019-12-08

6.  CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer's disease.

Authors:  Simone M Crivelli; Qian Luo; Jo A A Stevens; Caterina Giovagnoni; Daan van Kruining; Gerard Bode; Sandra den Hoedt; Barbara Hobo; Anna-Lena Scheithauer; Jochen Walter; Monique T Mulder; Christopher Exley; Matthew Mold; Michelle M Mielke; Helga E De Vries; Kristiaan Wouters; Daniel L A van den Hove; Dusan Berkes; María Dolores Ledesma; Joost Verhaagen; Mario Losen; Erhard Bieberich; Pilar Martinez-Martinez
Journal:  Alzheimers Res Ther       Date:  2021-02-17       Impact factor: 6.982

7.  White matter alterations in Alzheimer's disease without concomitant pathologies.

Authors:  I Ferrer; P Andrés-Benito
Journal:  Neuropathol Appl Neurobiol       Date:  2020-05-01       Impact factor: 8.090

8.  1700 nm optical coherence microscopy enables minimally invasive, label-free, in vivo optical biopsy deep in the mouse brain.

Authors:  Jun Zhu; Hercules Rezende Freitas; Izumi Maezawa; Lee-Way Jin; Vivek J Srinivasan
Journal:  Light Sci Appl       Date:  2021-07-14       Impact factor: 17.782

9.  Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease.

Authors:  Emelie Andersson; Shorena Janelidze; Björn Lampinen; Markus Nilsson; Antoine Leuzy; Erik Stomrud; Kaj Blennow; Henrik Zetterberg; Oskar Hansson
Journal:  Neurobiol Aging       Date:  2020-07-25       Impact factor: 4.673

10.  Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer's disease.

Authors:  Xinwen Zhang; Rihua Wang; Di Hu; Xiaoyan Sun; Hisashi Fujioka; Kathleen Lundberg; Ernest R Chan; Quanqiu Wang; Rong Xu; Margaret E Flanagan; Andrew A Pieper; Xin Qi
Journal:  Sci Adv       Date:  2020-12-04       Impact factor: 14.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.